Salud financiera de hoja de balance de Capral

Salud financiera controles de criterios 6/6

Capral tiene unos fondos propios totales de A$197.7M y una deuda total de A$0.0, lo que sitúa su ratio deuda/fondos propios en 0%. Sus activos y pasivos totales son A$431.6M y A$233.9M respectivamente. Capral El EBIT de la empresa es de A$37.1M, por lo que su ratio de cobertura de intereses es de 5.5. Su tesorería e inversiones a corto plazo ascienden a A$41.2M.

Información clave

Ratio deuda-patrimonio

AU$0

Deuda

Ratio de cobertura de intereses	6.4x
Efectivo	AU$59.46m
Patrimonio	AU$204.73m
Total pasivo	AU$220.47m
Activos totales	AU$425.20m

Actualizaciones recientes sobre salud financiera

No hay actualizaciones

Recent updates

Are Capral's (ASX:CAA) Statutory Earnings A Good Guide To Its Underlying Profitability?

Jan 03

Returns On Capital - An Important Metric For Capral (ASX:CAA)

Dec 13

Capral (ASX:CAA) Has Gifted Shareholders With A Fantastic 118% Total Return On Their Investment

Nov 25

The Trends At Capral (ASX:CAA) That You Should Know About

Jul 16

Análisis de la situación financiera

Pasivos a corto plazo: CAALos activos a corto plazo (A$285.7M) de la empresa superan a sus pasivos a corto plazo (A$155.5M).

Pasivo a largo plazo: CAALos activos a corto plazo (A$285.7M) superan a sus pasivos a largo plazo (A$78.4M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: CAA is debt free.

Reducción de la deuda: CAA no tenía deudas hace 5 años.

Cobertura de la deuda: CAA has no debt, therefore it does not need to be covered by operating cash flow.

Cobertura de intereses: CAA no tiene deuda, por lo que la cobertura del pago de intereses no es motivo de preocupación.

Hoja de balance

Descubre empresas con salud financiera

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Salud financiera de hoja de balance de Capral

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Recent updates

Capral Limited to Report Fiscal Year 2024 Results on Feb 27, 2025

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Capral Limited to Report Fiscal Year 2023 Results on Feb 23, 2024

MD, CEO & Non Independent Director recently sold AU$326k worth of stock

New major risk - Revenue and earnings growth

First half 2023 earnings released: EPS: AU$0.93 (vs AU$1.27 in 1H 2022)

Capral Limited Declares Fully Franked Interim Dividend for the Half Year Ended 30 June 2023, Payable on 15 September 2023

Now 20% undervalued after recent price drop

Now 21% undervalued after recent price drop

MD, CEO & Non Independent Director exercised options and sold AU$366k worth of stock

Full year 2022 earnings released: EPS: AU$2.31 (vs AU$2.52 in FY 2021)

Capral Limited to Report Fiscal Year 2022 Results on Feb 24, 2023

Capral Limited Introduces Local Lower Carbon Aluminium

Capral Limited Revises Earnings Guidance for the Year 2022

Upcoming dividend of AU$0.20 per share

Capral Limited (ASX:CAA) entered into an agreement to acquire Certain Assets of Aluminium Industries of Australia Pty. Ltd. for AUD 0.7 million.

First half 2022 earnings released: EPS: AU$1.27 (vs AU$0.93 in 1H 2021)

Capral Limited (ASX:CAA) entered into an agreement to acquire Certain Assets of Aluminium Industries of Australia Pty. Ltd. for AUD 0.7 million.

Capral Limited Announces Resignation of Phil Jobe as Director, Member of the Audit & Risk Committee and Member of the Remuneration & Nomination Committee

MD, CEO & Non Independent Director recently bought AU$176k worth of stock

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Capral Limited Announces Fully Franked CAA - Ordinary Fully Paid Dividend for the Period of Six Months Ended 31 December 2021, Payable on 25 March 2022

Capral Limited, Annual General Meeting, Apr 27, 2022

Capral Limited Announces Management Changes

First half 2021 earnings released: EPS AU$0.93 (vs AU$0.29 in 1H 2020)

Investor sentiment improved over the past week

New 90-day high: AU$7.00

Should You Buy Capral Limited (ASX:CAA) For Its Upcoming Dividend?

Full year 2020 earnings released: EPS AU$1.57 (vs AU$0.26 loss in FY 2019)

Are Capral Limited's (ASX:CAA) Mixed Financials Driving The Negative Sentiment?

Capral Limited (ASX:CAA) completed the acquisition of The G James Smithfield extrusion plant from G James Extrusion Co Pty. Ltd.

You Have To Love Capral Limited's (ASX:CAA) Dividend

Are Capral's (ASX:CAA) Statutory Earnings A Good Guide To Its Underlying Profitability?

New 90-day high: AU$5.73

Capral Limited (ASX:CAA) entered into an agreement to acquire The G James Smithfield extrusion plant from G James Extrusion Co Pty. Ltd. for approximately AUD 8 million.

Returns On Capital - An Important Metric For Capral (ASX:CAA)

Capral Limited Announces Change of Company Secretary

Capral (ASX:CAA) Has Gifted Shareholders With A Fantastic 118% Total Return On Their Investment

Capral Limited to Report Fiscal Year 2020 Results on Feb 26, 2021

Capral Limited, Annual General Meeting, Apr 28, 2021

New 90-day high: AU$5.26

Earnings released

The Trends At Capral (ASX:CAA) That You Should Know About

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera